Sign In
Free Newsletter
Former MD CEO charged with insider trading tied to COVID vaccine contamination
An ex-executive of Gaithersburg-based Emergent BioSolutions was charged with selling stock while knowing about problems at a Baltimore plant.
House panel alleges cover-up by Baltimore vaccine maker
Executives at Emergent BioSolutions' Baltimore factory covered up quality control problems that led to more than 400 million doses of coronavirus vaccines needing to be trashed, congressional investigators said.
Emergent’s Baltimore facility cleared for deal sending COVID vaccines to Canada
Emergent BioSolutions' Baltimore facility was found to be compliant after an inspection concerning its production of the Johnson & Johnson COVID-19 vaccine.
US cancels Emergent BioSolutions’ multimillion-dollar vaccine contract
The federal government has canceled a multimillion dollar deal with Maryland-based vaccine manufacturer Emergent BioSolutions.
Emergent BioSolutions secures $90M COVID vaccine development, manufacturing agreement
Gaithersburg-based Emergent BioSolutions Inc. and Providence Therapeutics have entered into an agreement to support Providence's COVID-19 vaccine development.
FDA letting troubled COVID vaccine factory in Baltimore restart
The FDA is allowing the problem-plagued Baltimore factory of Emergent BioSolutions to resume production of the Johnson & Johnson COVID-19 vaccine.
Investor sues Emergent BioSolutions for alleged fraud, seeks class action
Emergent BioSolutions Inc.’s ruination of 15 million doses of COVID-19 vaccine at its Baltimore plant was not as unexpected as the Gaithersburg-based company would have the public believe, an investor […]
Emergent’s $261M option on vaccine contract exercised
A Gaithersburg life sciences firm that focuses on public health threats expects to receive $261 million after a federal agency exercised an option on its anthrax vaccine contract.
